Found: 15
Select item for more details and to access through your institution.
Discrimination-based sample size calculations for multivariable prognostic models for time-to-event data.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome.
- Published in:
- 2013
- By:
- Publication type:
- journal article
A multi-arm multi-stage clinical trial design for binary outcomes with application to tuberculosis.
- Published in:
- 2013
- By:
- Publication type:
- journal article
When should factorial designs be used for late-phase randomised controlled trials?
- Published in:
- Clinical Trials, 2024, v. 21, n. 2, p. 162, doi. 10.1177/17407745231206261
- By:
- Publication type:
- Article
A comparison of different population-level summary measures for randomised trials with time-to-event outcomes, with a focus on non-inferiority trials.
- Published in:
- Clinical Trials, 2023, v. 20, n. 6, p. 594, doi. 10.1177/17407745231181907
- By:
- Publication type:
- Article
Treatment selection in multi-arm multi-stage designs: With application to a postpartum haemorrhage trial.
- Published in:
- Clinical Trials, 2023, v. 20, n. 1, p. 71, doi. 10.1177/17407745221136527
- By:
- Publication type:
- Article
Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3).
- Published in:
- Clinical Trials, 2022, v. 19, n. 1, p. 52, doi. 10.1177/17407745211049829
- By:
- Publication type:
- Article
The DURATIONS randomised trial design: Estimation targets, analysis methods and operating characteristics.
- Published in:
- Clinical Trials, 2020, v. 17, n. 6, p. 644, doi. 10.1177/1740774520944377
- By:
- Publication type:
- Article
Adding new experimental arms to randomised clinical trials: Impact on error rates.
- Published in:
- Clinical Trials, 2020, v. 17, n. 3, p. 273, doi. 10.1177/1740774520904346
- By:
- Publication type:
- Article
Rethinking non-inferiority: a practical trial design for optimising treatment duration.
- Published in:
- Clinical Trials, 2018, v. 15, n. 5, p. 477, doi. 10.1177/1740774518778027
- By:
- Publication type:
- Article
Optimisation of pharmacy content in clinical cancer research protocols: Experience of the United Kingdom Chemotherapy and Pharmacy Advisory Service.
- Published in:
- Clinical Trials, 2015, v. 12, n. 3, p. 257, doi. 10.1177/1740774515569610
- By:
- Publication type:
- Article
Comments on design and monitoring of survival trials in complex scenarios.
- Published in:
- 2019
- By:
- Publication type:
- letter
Sharing data from clinical trials: the rationale for a controlled access approach.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Impact of lack-of-benefit stopping rules on treatment effect estimates of two-arm multi-stage (TAMS) trials with time to event outcome.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Can p53 staining be used to identify patients with aggressive superficial bladder cancer?
- Published in:
- Journal of Pathology, 2003, v. 200, n. 1, p. 74, doi. 10.1002/path.1293
- By:
- Publication type:
- Article